150,000 Shares in CeriBell (NASDAQ:CBLL) Purchased by RTW Investments LP

RTW Investments LP purchased a new position in shares of CeriBell (NASDAQ:CBLL - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 150,000 shares of the company's stock, valued at approximately $3,882,000. RTW Investments LP owned approximately 0.42% of CeriBell at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Legal & General Group Plc purchased a new stake in shares of CeriBell during the 4th quarter worth about $32,000. Summit Investment Advisors Inc. bought a new stake in CeriBell in the fourth quarter worth approximately $33,000. Tower Research Capital LLC TRC bought a new stake in CeriBell in the fourth quarter worth approximately $37,000. BNP Paribas Financial Markets bought a new stake in CeriBell in the fourth quarter worth approximately $43,000. Finally, PNC Financial Services Group Inc. bought a new stake in CeriBell in the fourth quarter worth approximately $47,000.

Analysts Set New Price Targets

Several analysts have commented on CBLL shares. Canaccord Genuity Group reissued a "buy" rating and issued a $33.00 target price on shares of CeriBell in a research report on Wednesday, February 26th. LADENBURG THALM/SH SH started coverage on CeriBell in a research note on Friday, April 4th. They issued a "buy" rating and a $32.00 price objective on the stock. Seven investment analysts have rated the stock with a buy rating, According to data from MarketBeat, CeriBell presently has a consensus rating of "Buy" and a consensus target price of $32.50.

CeriBell Stock Performance

NASDAQ CBLL traded down $0.14 during trading on Monday, hitting $17.83. The company's stock had a trading volume of 335,190 shares, compared to its average volume of 276,630. The firm has a 50 day moving average price of $17.43 and a 200 day moving average price of $22.32. CeriBell has a 52 week low of $10.01 and a 52 week high of $32.75.

CeriBell (NASDAQ:CBLL - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported ($0.36) EPS for the quarter, beating the consensus estimate of ($0.43) by $0.07. The company had revenue of $20.49 million for the quarter, compared to analyst estimates of $19.30 million. On average, equities analysts expect that CeriBell will post -2.46 EPS for the current year.

Insider Activity at CeriBell

In other news, CEO Xingjuan Chao sold 25,000 shares of CeriBell stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $16.96, for a total transaction of $424,000.00. Following the sale, the chief executive officer now directly owns 727,151 shares in the company, valued at approximately $12,332,480.96. The trade was a 3.32% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold a total of 49,700 shares of company stock worth $796,434 in the last ninety days. 20.10% of the stock is currently owned by insiders.

CeriBell Company Profile

We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting.